Skip to content
Forging a Faster Path for Gene Therapies episode artwork

Apr 11, 2024 28 min

Forging a Faster Path for Gene Therapies

from RARECast

The Bespoke Gene Therapy Consortium, a public-private partnership backed by the Foundation for the National Institutes of Health, in February published its first playbook. The playbook provides a roadmap for streamlining product development and navigation of the regulatory pathway for AAV gene therapies with the goal of getting new treatments to patients sooner. We spoke to Courtney Silverthorn, vice president of strategic alliances and innovation for the Foundation for the National Institutes of Health; and Sharon King, manager of advocacy and community engagement for Aldevron and founder and president of Taylor’s Tale; about the Bespoke Gene Therapy Consortium, its new playbook, and how it will help gene therapy developers get their medicines to patients faster.

Episode details come from the podcast's RSS feed.

Embed this episode

Courtney Silverthorn, vice president of strategic alliances and innovation for the Foundation for the National Institutes of Health; and Sharon King, manager of advocacy and community engagement for Aldevron and founder and president of Taylor’s Tale; discuss the Bespoke Gene Therapy Consortium, its new playbook, and how it will help gene therapy developers get their medicines to patients faster.

Ready to play

Forging a Faster Path for Gene Therapies

0:00 28:28

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of RARECast?

This episode is 28 minutes long.

When was this RARECast episode published?

This episode was published on April 11, 2024.

Can I download this RARECast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.